ArticleCell death & disease2026

Combining PD-L1 blockade with a second-generation HSP110 inhibitor enhances antitumor immunity in colorectal cancer.

María Jimena Abrey-Recalde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.